High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia
Abstract
Apolipoprotein E ε4 allele (APOE ε4) increases the apolipoprotein E (apoE) protein levels in Alzheimer's disease (AD) cerebrospinal fluid (CSF). Thus, we hypothesized that apoE levels were also associated with the APOE genotype, and amyloid‐β (Aβ)‐associated clinical, functional, and imaging parameters in patients with Lewy body‐associated disorders (LBD). Indeed, similar to AD, patients with LBD displayed high CSF apoE levels (greatest in patients with dementia with LBD), and this was linked to APOE ε4. High CSF apoE protein correlated positively with CSF soluble amyloid precursor protein, total tau, and cortical and striatal Pittsburgh compound B retention; and correlated negatively with CSF Aβ 42, cognitive tests scores, and glucose uptake ratio in the temporal and parietal cortices. APOE ε4‐triggered accumulation of apoE in CSF is related to Aβ‐associated clinical and functional imaging parameters in LBD. Accordingly, therapeutic strategies aimed at reducing apoE levels in the brain should be explored not only in AD but also in LBD, particularly when accompanied with dementia.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Human studies of cerebrospinal fluid with various Alzheimer disease-related outcomes are conflicting, including differences in APOE genotype stratified analyses.
“Human studies of cerebrospinal fluid with various Alzheimer diseaseerelated outcomes are conflicting, including differences in the APOE genotype stratified analyses [105,106].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [106]
Cites
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
Riddell, D. R., Zhou, H., Atchison, K., Warwick, H. K., Atkinson, P. J., Jefferson, J., Xu, L., Aschmies, S., Kirksey, Y., Hu, Y., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1972-08.2008 · Cited by 342 · see citing works
Gong, J.-S., Kobayashi, M., Hayashi, H., Zou, K., Sawamura, N., Fujita, S. C., Yanagisawa, K., & Michikawa, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203934200 · Cited by 214 · see citing works
Kim, J., Jiang, H., Park, S., Eltorai, A. E. M., Stewart, F. R., Yoon, H., Basak, J. M., Finn, M. B., & Holtzman, D. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3773-11.2011 · Cited by 199 · cited 1× · see citing works
“These findings have been confirmed recently in a mouse model of Ab amyloidosis, in which genetic manipulation of the APOE gene dosage demonstrated that decreasing human apoE levels, regardless of isoform status, results in significantly decreased Ab plaque deposition and microglial activation [20].”
BackgroundTerwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J.-Å., Holtzman, D. M., & Heneka, M. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6546-10.2011 · Cited by 181 · see citing works
Belinson, H., Lev, D., Masliah, E., & Michaelson, D. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5633-07.2008 · Cited by 101 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Plasma levels of apolipoprotein <scp>E</scp> and risk of dementia in the general population
Rasmussen, K. L., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2015) · Annals of Neurology · doi:10.1002/ana.24326 · Cited by 156 · see citing works
Rasmussen, K. L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.037 · Cited by 125 · see citing works
- Authors
- Vijayaraghavan, S., Maetzler, W., Reimold, M., Lithner, C. U., Liepelt‐Scarfone, I., Berg, D., & Darreh‐Shori, T.
- Affiliations
- Karolinska Institutet (SE)
- German Center for Neurodegenerative Diseases (DE)
- University of Tübingen (DE)
- Corresponding author
- Darreh‐Shori, Taher
- ORCID
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2013-08-26
- Volume
- 10
- Issue
- 5
- Pages
- 530
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2082564633
- Cited by
- 24
- References
- 6
- Citations by year
- 2025: 1 · 2024: 6 · 2020: 1 · 2019: 3 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 1
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- DZNE Pub (submittedVersion)
- Funders
- American Liver Foundation
- Stockholms Läns Landsting
- Karolinska Institutet
- Loo och Hans Ostermans Stiftelse för Medicinsk Forskning
- Stiftelsen Olle Engkvist Byggmästare
- Stiftelsen för Gamla Tjänarinnor
- Gun och Bertil Stohnes Stiftelse
- Åke Wiberg Stiftelse
- Stiftelsen Ragnhild och Einar Lundströms Minne
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- apolipoprotein E, APOE ε4
- MeSH terms
- Aged, Aged, 80 and over, Aniline Compounds, Apolipoproteins E, Brain, Carbon Radioisotopes, Female, Glucose, Humans, Male, Middle Aged, Neuropsychological Tests, Peptide Fragments, Thiazoles, Cohort Studies, Biomarkers, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, tau Proteins, Radiopharmaceuticals, Fluorodeoxyglucose F18, Lewy Body Disease, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review